100 million euro fund for biotechnology launched in France
Early stage biotechnology companies will gain access to a major source of funding in France, with €50 million being set aside by both the French state bank (BpiFrance) and pharmaceutical company Sanofi. If suitable other partners engage with the fund, up to €250 million could eventually become available.
In a related announcement, France is also set to launch a new process for market access of medicines, reducing the time frame from 275 days to 180 by 2022.
Read this story on the Reuters news page.
